BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 22, 2008
View Archived Issues
Survival Data Could Threaten Avastin in Lung Cancer Market
Analysts are predicting that Genentech Inc.'s Avastin could face stiff competition as a treatment for lung cancer from ImClone Systems Inc.'s Erbitux (Cetuximab) based on new data. (BioWorld Today)
Read More
Series B Round Gains $25M for Stromedix Fibrosis Trial
Read More
Inflammation Increases Fusion of Brain with Blood Stem Cells
Read More
Vernalis Takes $29M for Now, Giving Up Migraine Revenues
Read More
Other News To Note
Read More
Clinic Roundup
Read More
ECCMID Roundup
Read More